# Tumor DNA Vaccines Sector

Canonical URL: https://biopharmsignal.com/sector/tumor-dna-vaccines

Tumor DNA Vaccines is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Tumor DNA Vaccines, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Tumor DNA Vaccines: 1

## Recent Sector News

- 2023-06-23 20:10 EST — INO — [INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions](https://biopharmsignal.com/news/INO/inovio-announces-notice-of-pendency-and-proposed-settlement-of-stockholder-deriv-04e91627) — Source: Inovio Pharmaceuticals
- 2018-12-04 13:00 EST — INO — [Inovio Announces Initiation of “MD Anderson’s HPV-Related Cancers Moon Shot” Phase 2 Trial in New HPV Indications](https://biopharmsignal.com/news/INO/inovio-announces-initiation-of-md-anderson-s-hpv-related-cancers-moon-shot-phase-81452129) — Source: Inovio Pharmaceuticals
- 2018-11-27 02:35 EST — INO — [Inovio, DNA 암호화 단일클론 항체(dMAb™) 플랫폼의 효능 입증하는 임상전 논문 3건과 2019년 첫 임상시험 계획 발표](https://biopharmsignal.com/news/INO/inovio-dna-dmab-3-2019-575d456e) — Source: Inovio Pharmaceuticals
- 2018-11-27 02:35 EST — INO — [イノビオ社、3件の前臨床試験で同社のDNAコード化モノクローナル抗体 (dMAb™) プラットフォームの効力をさらに実証し、2019年初旬の初回臨床試験に向けて準備を進める](https://biopharmsignal.com/news/INO/3-dna-dmab-2019-c3002d7b) — Source: Inovio Pharmaceuticals
- 2018-11-27 02:35 EST — INO — [Inovio在三項臨床前試驗結果文獻中進一步顯示Inovio的DNA編碼單克隆抗體（dMAb™）平台的療效，並準備在2019年初進行首次臨床試驗](https://biopharmsignal.com/news/INO/inovio-inovio-dna-dmab-2019-9b7c1150) — Source: Inovio Pharmaceuticals
- 2018-11-26 13:00 EST — INO — [Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Antibody (dMAb™) Platform in Three Preclinical Publications and Prepares for First Clinical Trial in Early 2019](https://biopharmsignal.com/news/INO/inovio-further-demonstrates-potency-of-its-dna-encoded-monoclonal-antibody-dmab--b9a5e51f) — Source: Inovio Pharmaceuticals
- 2018-11-15 13:00 EST — INO — [Inovio Prepares for Growth & Commercialization With Leadership Appointments](https://biopharmsignal.com/news/INO/inovio-prepares-for-growth-commercialization-with-leadership-appointments-5e578246) — Source: Inovio Pharmaceuticals
- 2018-11-08 21:05 EST — INO — [Inovio Pharmaceuticals Reports 2018 Third Quarter Financial Results](https://biopharmsignal.com/news/INO/inovio-pharmaceuticals-reports-2018-third-quarter-financial-results-86c44ce2) — Source: Inovio Pharmaceuticals
- 2018-11-05 13:00 EST — INO — [Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences](https://biopharmsignal.com/news/INO/inovio-pharmaceuticals-to-participate-in-upcoming-investment-conferences-f65ebaea) — Source: Inovio Pharmaceuticals
- 2018-10-26 06:28 EST — INO — [Inovio의 HIV 백신 PENNVAX®-GP, 피내 투여 시 강력하고 지속적인 항체, T세포 면역 반응 나타내](https://biopharmsignal.com/news/INO/inovio-hiv-pennvax-gp-t-c743ebf9) — Source: Inovio Pharmaceuticals
- 2018-10-25 12:00 EST — INO — [Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses](https://biopharmsignal.com/news/INO/inovio-hiv-vaccine-pennvax-gp-delivered-intradermally-generated-robust-long-term-3e8f08d2) — Source: Inovio Pharmaceuticals
- 2018-10-24 16:09 EST — INO — [Inovio Pharmaceuticals, 2018년 11월 8일 3분기 실적발표 실시](https://biopharmsignal.com/news/INO/inovio-pharmaceuticals-2018-11-8-3-33e594cb) — Source: Inovio Pharmaceuticals
- 2018-10-24 12:00 EST — INO — [Inovio Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 8, 2018](https://biopharmsignal.com/news/INO/inovio-pharmaceuticals-to-report-third-quarter-2018-financial-results-on-novembe-9356af3b) — Source: Inovio Pharmaceuticals
- 2018-10-23 01:35 EST — INO — [Inovio, INO-5150의 전립선암 환자 무진행 생존율 향상 및 PSA 배가 시간 지연 효과 발표](https://biopharmsignal.com/news/INO/inovio-ino-5150-psa-25f709c5) — Source: Inovio Pharmaceuticals
- 2018-10-22 12:00 EST — INO — [Inovio Presents Progression Free Survival  & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150](https://biopharmsignal.com/news/INO/inovio-presents-progression-free-survival-psa-doubling-time-improvements-in-pros-2df90cdf) — Source: Inovio Pharmaceuticals
- 2018-10-18 00:58 EST — INO — [Inovio의 DNA 암호화 단일클론 항체(dMAb™) 플랫폼, 긍정적 데이터 도출과 함께 특허 및 연구비 획득](https://biopharmsignal.com/news/INO/inovio-dna-dmab-6777cceb) — Source: Inovio Pharmaceuticals
- 2018-10-17 12:00 EST — INO — [イノビオ社によるDNAコード･モノクローナル抗体 (dMAb™) プラットフォーム、有望なデータ、特許、助成金を取得して進歩する](https://biopharmsignal.com/news/INO/dna-dmab-ee8e66b1) — Source: Inovio Pharmaceuticals
- 2018-10-17 12:00 EST — INO — [Inovio的DNA编码单克隆抗体（dMAbTM）平台在积极数据、专利和赠款方面取得进展](https://biopharmsignal.com/news/INO/inovio-dna-dmabtm-91dee9e5) — Source: Inovio Pharmaceuticals
- 2018-10-17 12:00 EST — INO — [Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Moves Ahead with Positive Data, Patents and Grants](https://biopharmsignal.com/news/INO/inovio-s-dna-encoded-monoclonal-antibody-dmab-platform-moves-ahead-with-positive-635295ba) — Source: Inovio Pharmaceuticals
- 2018-10-15 12:00 EST — INO — [Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies](https://biopharmsignal.com/news/INO/inovio-s-ebola-vaccine-provides-100-protection-and-elicits-long-lasting-immune-r-2a5eaa6b) — Source: Inovio Pharmaceuticals

## Companies

- [INO](https://biopharmsignal.com/company/INO) — Inovio Pharmaceuticals